What DeepScribe Announced About SmartPrep for Oncology
DeepScribe said on 27 April 2026 that it launched SmartPrep, a product that gathers, sorts and summarises a patient record before an oncology appointment. The company says it behaves differently for a first consultation and a follow up: for a consultation it pulls together up to two years of records into a history of present illness that can flow into the visit note, and for a follow up it surfaces what happened in between, checks the status of earlier plan items and flags what is outstanding. DeepScribe says it reads labs, imaging, pathology, molecular and genetic results, outside records, visit notes and chart messages, can run up to seven days ahead, refreshes as new documents arrive, and shows a ranked checklist of items that may need attention. It says clinicians using SmartPrep report spending about one third as much time preparing for each patient as before, and that the product is reachable on the web, on iOS and inside the records systems its customers already use. It also says organisations using DeepScribe represent 90 percent of United States community oncology organisations and see about 40 percent of all cancer visits in the country.
Why DeepScribe SmartPrep Matters to Oncology Practice Leaders
Ambient documentation tools have mostly attacked the work after the visit. Pre-visit reading is the other half of the unpaid day, and it is harder, because the software has to decide what matters rather than write down what was said. That is why the checklist is the interesting part and also the risky part: a ranked list of what needs attention is a judgement about a cancer patient, even when a clinician makes the final call. One third of the preparation time is a clinician report, not a measured study, and DeepScribe does not say how many clinicians or over how long. The 90 percent and 40 percent figures are the company describing its own reach and are worth checking against how you define a community oncology organisation.
Where the DeepScribe Update Comes From
DeepScribe is the original record behind this update. It tells us what the company published. This brief adds the market context and the method we would use to test the development against other evidence.
How We Would Research DeepScribe SmartPrep
The source gives us the starting point. This is how we would build the next layer of research around it.
- We would ask DeepScribe how often SmartPrep misses something a clinician then had to find, because what the checklist leaves out is the whole risk.
- Then we would ask how the one third preparation figure was collected, from how many clinicians and over how long.
- We would test it on a complicated patient with records from outside the practice, since pulling in outside records is the claim most likely to break.